UY31415A1 - Procedimiento para la preparacion de medetomidina - Google Patents

Procedimiento para la preparacion de medetomidina

Info

Publication number
UY31415A1
UY31415A1 UY31415A UY31415A UY31415A1 UY 31415 A1 UY31415 A1 UY 31415A1 UY 31415 A UY31415 A UY 31415A UY 31415 A UY31415 A UY 31415A UY 31415 A1 UY31415 A1 UY 31415A1
Authority
UY
Uruguay
Prior art keywords
medetomidine
procedure
preparation
acid addition
addition salt
Prior art date
Application number
UY31415A
Other languages
English (en)
Inventor
Kristian Bragg
Jonathan Cranke
Muhammad Raza
Rasik Somaiya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31415A1 publication Critical patent/UY31415A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un procedimiento para preparar Medetomidina de Formula (I): o su sal de adicion de ácido, y dicho procedimiento consiste en: (i) hacer reaccionar alcohol 2,3-dimetil-metilbencílico con N-trimetilsililimidazol y, si se desea, convertir a Medetomidina en su sal de adicion de ácido (ver solapa reiv)
UY31415A 2007-10-24 2008-10-22 Procedimiento para la preparacion de medetomidina UY31415A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0720891A GB2453982B (en) 2007-10-24 2007-10-24 Chemical process for the preparation of Medetomidine

Publications (1)

Publication Number Publication Date
UY31415A1 true UY31415A1 (es) 2009-05-29

Family

ID=38829878

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31415A UY31415A1 (es) 2007-10-24 2008-10-22 Procedimiento para la preparacion de medetomidina

Country Status (6)

Country Link
AR (1) AR068952A1 (es)
CL (1) CL2008003185A1 (es)
GB (1) GB2453982B (es)
PE (1) PE20091088A1 (es)
UY (1) UY31415A1 (es)
WO (1) WO2009053709A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101921234B (zh) * 2009-06-12 2012-05-30 中国中化股份有限公司 一种制备美托咪啶的方法
CN102753532B (zh) * 2009-12-09 2015-05-13 I-技术有限公司 美托咪定的制备方法
KR101932206B1 (ko) 2011-07-22 2018-12-24 캠브렉스 칼스코가 아베 4-치환 이미다졸의 신규 제조방법
WO2012172119A2 (en) * 2012-05-08 2012-12-20 Lonza Ltd Method for the preparation of medetomidine
EP2847173B1 (en) * 2012-05-08 2015-12-30 Lonza Ltd Method for preparation of medetomidine
SG11201405611SA (en) 2012-05-08 2014-11-27 Lonza Ag Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal
JP5777841B2 (ja) 2012-06-28 2015-09-09 ロンザ・リミテッド クロロアセトンを用いてメデトミジンを調製するための方法
CA2866441C (en) 2012-06-28 2017-01-17 Lonza Ltd. Method for preparation of 2-(2,3-dimethylphenyl)-1-propanal with chloroacetone
CN106588777A (zh) * 2015-10-16 2017-04-26 江苏开元医药化工有限公司 一种盐酸右美托咪定的工业化制备方法
KR20240148807A (ko) 2022-03-22 2024-10-11 옵쉐스트바 스 아그라니첸너이아트볫스트벤너스찌유 "빅-즈다로비예쥐보트니흐" 메데토미딘 및 그 유도체의 제조 방법
CN114671811A (zh) * 2022-04-14 2022-06-28 南京正科医药股份有限公司 一种右美托咪定拆分副产物的外消旋化回收方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use

Also Published As

Publication number Publication date
GB0720891D0 (en) 2007-12-05
GB2453982A (en) 2009-04-29
PE20091088A1 (es) 2009-07-20
WO2009053709A1 (en) 2009-04-30
CL2008003185A1 (es) 2009-03-06
AR068952A1 (es) 2009-12-16
GB2453982B (en) 2009-09-16

Similar Documents

Publication Publication Date Title
UY31415A1 (es) Procedimiento para la preparacion de medetomidina
UY29857A1 (es) Derivados de la 4-amino-quinazolina, su preparación y su aplicación en terapéutica.
MX2010008040A (es) Derivados de pirimidina 5-fluoro como fungicidas.
GB0818255D0 (en) Isolation and identification of glycosaminoglycans
WO2009158606A3 (en) Structure, synthesis, and applications for oligo phenylene ethynylenes
BR112012015033A2 (pt) composição não fermentada que tem a capacidade de aumentar a formação de ácido burítico no cólon, composição não fermentada seca que tem a capacidade de aumentar a formação de ácido burítico no cólon e uso de composição não fermentada
UY32477A (es) Proteínas de unión a il-17
BRPI0514584A (pt) método para preparar irbesartan e intermediários do mesmo
JOP20180077A1 (ar) تركيبات وطرق لحمض صفراوي تخليقي
AR064658A1 (es) Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma
WO2009103432A3 (en) Covalently binding imaging probes
UY30650A1 (es) Sal de acido p-toluensulfonico de 5-amino-3-(2??-o-acetil-3??-desoxi-b-d-ribofuranosil)-3h-tiazol[4,5-d]pirimidin-2-ona y métodos de preparacion
IN2012DN00539A (es)
MX2009008560A (es) Sondas para diagnostico por la imagen.
IL185480A0 (en) Topical formulations of borinic acid antibodies and their methods of use
MX2010006636A (es) Uso de derivados de acido tetramico para controlar nematodos.
BRPI0807798A2 (pt) " aperfeiçoamento do crescimento celular ".
AR063597A1 (es) Nueva sal
RU2005114640A (ru) Способ получения n-метилен-4h-1,3,5-дитиазинил-5(6h)амина
EP2733134A3 (en) Alternative to tetrazene
IN2012DN00337A (es)
UY29858A1 (es) Derivados de la 1-amino-ftalazina sustituida, su preparación y su aplicación en terapéutica
ITPG20090012A1 (it) Preparato ad uso topico penieno per ritardare l'eiaculazione
UA60180U (ru) Способ культивирования личинок гельминтов у животных
PL392128A1 (pl) Sposób transplantacji blastocyst świńskich do macicy oraz zestaw do jego realizacji

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20171017